Immunoglobulin G3 antibodies specific for the 19-kilodalton carboxyl-terminal fragment of Plasmodium yoelii merozoite surface protein 1 transfer protection to mice deficient in Fc-gammaRI receptors.
about
Induction of strain-transcending immunity against Plasmodium chabaudi adami malaria with a multiepitope DNA vaccineGrowth-inhibitory antibodies are not necessary for protective immunity to malaria infection.Suppressive and additive effects in protection mediated by combinations of monoclonal antibodies specific for merozoite surface protein 1 of Plasmodium yoelii.Different regions of the malaria merozoite surface protein 1 of Plasmodium chabaudi elicit distinct T-cell and antibody isotype responses.Complement contributes to protective immunity against reinfection by Plasmodium chabaudi chabaudi parasites.Towards a blood-stage vaccine for malaria: are we following all the leads?Immunity to asexual blood stage malaria and vaccine approaches.Plasmodium falciparum: immunization with MSP1-42 induced non-inhibitory antibodies that have no blocking activities but enhanced the potency of inhibitory anti-MSP1-42 antibodies.Fine specificity of serum antibodies to Plasmodium falciparum merozoite surface protein, PfMSP-1(19), predicts protection from malaria infection and high-density parasitemiaAntibodies generated against conserved antigens expressed by bacteria and allergen-bearing fungi suppress airway disease.Protection against Plasmodium chabaudi malaria induced by immunization with apical membrane antigen 1 and merozoite surface protein 1 in the absence of gamma interferon or interleukin-4.Fc-receptors and immunity to malaria: from models to vaccines.Susceptibility of the different developmental stages of the asexual (schizogonic) erythrocyte cycle of Plasmodium chabaudi chabaudi to hyperimmune serum, immunoglobulin (Ig)G1, IgG2a and F(ab')2 fragments.Parasite-specific IgM plays a significant role in the protective immune response to asexual erythrocytic stage Plasmodium chabaudi AS infection.
P2860
Q33214292-C0933DBA-B0D5-4E2D-9D86-418182B9AAE0Q33613813-416C5536-2E92-4695-A9C7-191B2A41582DQ33711883-E4A3F698-AAF3-45F6-AA15-F1A23E6B14FDQ34006785-45048D41-96D0-4056-AD67-14BE8A19AF50Q34007833-4DE9C52B-23D2-4151-9A48-9CEDDF97778FQ34572160-53AF574A-C94F-4D19-8A34-981C2282457CQ34842236-52C72004-169E-4DEE-847A-10B5838E1E74Q35762375-A0DCB848-832A-46A5-BE41-31064EF8B91DQ36576319-FA88E26D-A969-4CBC-B261-46BD5B73F407Q37478109-085F77CB-E5DF-409A-97D8-CDF47A7605D9Q37523881-F9DCE5FE-639F-41A8-BD3C-51E99AB42B17Q37582419-526B3850-B6DE-4790-AF2F-9F9DADABC648Q47894554-9590138F-B1E9-4DEE-ABAE-BA20C5E3BDC8Q48011236-94968685-7F0C-4784-94DA-81CE5ADF03E5
P2860
Immunoglobulin G3 antibodies specific for the 19-kilodalton carboxyl-terminal fragment of Plasmodium yoelii merozoite surface protein 1 transfer protection to mice deficient in Fc-gammaRI receptors.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Immunoglobulin G3 antibodies s ...... cient in Fc-gammaRI receptors.
@ast
Immunoglobulin G3 antibodies s ...... cient in Fc-gammaRI receptors.
@en
Immunoglobulin G3 antibodies s ...... cient in Fc-gammaRI receptors.
@nl
type
label
Immunoglobulin G3 antibodies s ...... cient in Fc-gammaRI receptors.
@ast
Immunoglobulin G3 antibodies s ...... cient in Fc-gammaRI receptors.
@en
Immunoglobulin G3 antibodies s ...... cient in Fc-gammaRI receptors.
@nl
prefLabel
Immunoglobulin G3 antibodies s ...... cient in Fc-gammaRI receptors.
@ast
Immunoglobulin G3 antibodies s ...... cient in Fc-gammaRI receptors.
@en
Immunoglobulin G3 antibodies s ...... cient in Fc-gammaRI receptors.
@nl
P2093
P2860
P1476
Immunoglobulin G3 antibodies s ...... cient in Fc-gammaRI receptors.
@en
P2093
P2860
P304
P356
10.1128/IAI.68.5.3019-3022.2000
P407
P577
2000-05-01T00:00:00Z